October 31, 2011 – Accuray announced that more than 100 of its TomoDirect treatment modality systems are now in use at leading cancer centers throughout the world, offering patients the option of treatment with image-guided, intensity-modulated radiation therapy (IG-IMRT) for routine radiation therapy indications.
First delivered to the market in 2010, TomoDirect is a standard feature on the TomoHD treatment system. It is optimized for delivering radiation at fixed angles, making it highly efficient for whole breast radiotherapy and other cases where select beam angles are most appropriate. Global adoption continues, with over 75 percent of system orders in the past six months including TomoDirect.
The Institute for Image-Guided RadioThereapy (IIGRT), in Westchester, Rye, N.Y., is one of the first centers in the world to offer TomoDirect treatments. IIGRT performs both whole breast and accelerated partial breast irradiation (APBI) with TomoDirect.
"IIGRT has been using the TomoTherapy System since 2007 and we have significantly increased our treatment capacity with the addition of TomoDirect last year, because we can now offer TomoTherapy to an expanded patient population," said Daniel Fass, M.D., director of IIGRT. "TomoDirect offers a highly accurate and convenient method for delivering APBI. This allows us to offer many breast cancer patients a shorter course of high quality radiation therapy treatments. We also use TomoDirect for conventional breast treatments when it offers a dosimetric advantage over Helical TomoTherapy."
Accuray's TomoHD Treatment System is a comprehensive solution that efficiently handles clinical indications of any complexity. The system offers both TomoDirect and TomoHelical treatment modes to allow clinicians to deliver treatment options for a range of clinical indications and enables daily 3-D computed tomography (CT) imaging of every patient, prior to each treatment, to maximize treatment accuracy. The TomoDirect modality is efficient in applying multiple targeted radiation beams to the tumor for more routine cases while TomoHelical is designed for more complex cases, delivering radiation throughout multiple 360-degree gantry rotations.
For more information: www.accuray.com
October 31, 2011 – Accuray announced that more than 100 of its TomoDirect treatment modality systems are now in use at leading cancer centers throughout the world, offering patients the option of treatment with image-guided, intensity-modulated radiation therapy (IG-IMRT) for routine radiation therapy indications.
First delivered to the market in 2010, TomoDirect is a standard feature on the TomoHD treatment system. It is optimized for delivering radiation at fixed angles, making it highly efficient for whole breast radiotherapy and other cases where select beam angles are most appropriate. Global adoption continues, with over 75 percent of system orders in the past six months including TomoDirect.
The Institute for Image-Guided RadioThereapy (IIGRT), in Westchester, Rye, N.Y., is one of the first centers in the world to offer TomoDirect treatments. IIGRT performs both whole breast and accelerated partial breast irradiation (APBI) with TomoDirect.
"IIGRT has been using the TomoTherapy System since 2007 and we have significantly increased our treatment capacity with the addition of TomoDirect last year, because we can now offer TomoTherapy to an expanded patient population," said Daniel Fass, M.D., director of IIGRT. "TomoDirect offers a highly accurate and convenient method for delivering APBI. This allows us to offer many breast cancer patients a shorter course of high quality radiation therapy treatments. We also use TomoDirect for conventional breast treatments when it offers a dosimetric advantage over Helical TomoTherapy."
Accuray's TomoHD Treatment System is a comprehensive solution that efficiently handles clinical indications of any complexity. The system offers both TomoDirect and TomoHelical treatment modes to allow clinicians to deliver treatment options for a range of clinical indications and enables daily 3-D computed tomography (CT) imaging of every patient, prior to each treatment, to maximize treatment accuracy. The TomoDirect modality is efficient in applying multiple targeted radiation beams to the tumor for more routine cases while TomoHelical is designed for more complex cases, delivering radiation throughout multiple 360-degree gantry rotations.
For more information: www.accuray.com
March 28, 2024 
